Bvf Inc/il
Bvf Inc/il reported 44 stocks worth $3.9B in its 13F filing for Q2 2026, filed Aug 14, 2026. Its largest holdings are RVMD (14.2%), KYMR (11.3%) and Xoma Royalty Corporation (8.3%). Compared with Q1 2026, the fund opened new positions in QTTB, ABSI and SGMT, added to RVMD, ALKS and AVTX, trimmed KYMR, GPCR and NKTR and sold out of CMPX, SEPN and IMUX.
Holdings
| # | Stock | Value | Weight | Shares | Change | Shares, 8 qtrs | Held |
|---|---|---|---|---|---|---|---|
| 1 |  RVMD Revolution Medicines Inc | $555M | 14.2% | 3M | +108K (+4%) | 8 of 8 | |
| 2 |  KYMR Kymera Therapeutics Inc | $444M | 11.3% | 3.9M | −1.6M (−30%) | 8 of 8 | |
| 3 | XOMA ROYALTY CORPORATION | $323M | 8.3% | 7.6M | +5M (+193%) | 8 of 8 | |
| 4 |  MLTX Moonlake Immunotherapeutics | $312M | 8.0% | 16M | No change | 8 of 8 | |
| 5 |  GHRS GH Research PLC | $233M | 6.0% | 8.7M | No change | 8 of 8 | |
| 6 |  GPCR Structure Therapeutics Inc | $181M | 4.6% | 3.4M | −93K (−3%) | 8 of 8 | |
| 7 |  NKTR Nektar Therapeutics | $167M | 4.3% | 2.4M | −169K (−7%) | 4 of 8 | |
| 8 |  MIRM Mirum Pharmaceuticals Inc | $124M | 3.2% | 1.1M | −529K (−33%) | 8 of 8 | |
| 9 |  XNCR Xencor Inc | $115M | 2.9% | 7.1M | No change | 8 of 8 | |
| 10 |  ALKS Alkermes PLC | $113M | 2.9% | 2.2M | +155K (+8%) | 2 of 8 |
Positions at Jun 30, 2026, as reported. Change is against the fund's Q1 2026 filing; weight is the share of the fund's reported stocks.
Sold out
held in Q1 2026, gone in Q2 2026
Reported value
last 8 quartersThe value of the US stocks the fund reported, at quarter end prices. It moves with the market as well as with buying and selling.
Filings for Q2 2026
straight from the SEC| Filed | Form | Quarter | |
|---|---|---|---|
| Aug 14, 2026 | 13F-HR | Q2 2026 | SEC filing ↗ |
Other superinvestors
All hedge fund holdings →Bvf Inc/il 13F FAQ
What does Bvf Inc/il own?
Bvf Inc/il reported 44 stocks worth $3.9B in its 13F filing for Q2 2026, filed Aug 14, 2026. Its largest holdings are RVMD (14.2%), KYMR (11.3%) and Xoma Royalty Corporation (8.3%). The table above lists every position in the filing (the top 10 without an account).
What did Bvf Inc/il buy and sell in Q2 2026?
Compared with Q1 2026: 7 new positions, 6 added to, 8 trimmed and 4 sold out. New positions include QTTB, ABSI and SGMT. It sold all of CMPX, SEPN and IMUX.
When will Bvf Inc/il file its next 13F?
Holdings as of Sep 30, 2026 are due by Nov 16, 2026. The filing appears on this page within minutes of reaching the SEC.
How much is Bvf Inc/il's portfolio worth?
The Q2 2026 filing reports $3.9B in US stocks. That leaves out cash, bonds, short positions and most foreign holdings, so the fund's total assets are usually larger.
For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Holdings come from the fund's SEC Form 13F filings as reported and show positions at the end of the quarter, up to 45 days before the filing. The fund may have changed its positions since. A 13F leaves out short positions, cash, bonds and most foreign holdings. See all hedge fund holdings.